CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.35
-0.49 (-6.25%)
At close: Feb 5, 2026, 4:00 PM EST
7.53
+0.18 (2.45%)
Pre-market: Feb 6, 2026, 5:34 AM EST
CorMedix Employees
As of December 31, 2024, CorMedix had 65 total employees, including 64 full-time and 1 part-time employees. The number of employees decreased by 18 or -21.69% compared to the previous year.
Employees
65
Change (1Y)
-18
Growth (1Y)
-21.69%
Revenue / Employee
$3,296,980
Profits / Employee
$2,499,989
Market Cap
579.10M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 65 | -18 | -21.69% | 64 | 1 |
| Dec 31, 2023 | 83 | 42 | 102.44% | 82 | 1 |
| Dec 31, 2022 | 41 | 11 | 36.67% | 40 | 1 |
| Dec 31, 2021 | 30 | -5 | -14.29% | 29 | 1 |
| Dec 31, 2020 | 35 | 5 | 16.67% | 35 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Replimune Group | 479 |
| MeiraGTx Holdings | 409 |
| Prime Medicine | 214 |
| Rigel Pharmaceuticals | 164 |
| Gossamer Bio | 145 |
| Alpha Tau Medical | 125 |
| enGene Holdings | 82 |
| Altimmune | 59 |
CRMD News
- 3 days ago - CorMedix Therapeutics Announces Share Repurchase Program - GlobeNewsWire
- 7 days ago - CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026 - GlobeNewsWire
- 24 days ago - CorMedix Inc. (CRMD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 27 days ago - CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Why is CorMedix stock crashing today: is it worth buying on the dip? - Invezz
- 4 weeks ago - CorMedix Therapeutics Announces Leadership and Board Updates - GlobeNewsWire
- 4 weeks ago - CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - CorMedix Therapeutics Announces Positive Data From Ongoing Real World Evidence Study of DefenCath - GlobeNewsWire